While no previous study has examined the expression of CBR1 in breast cancer, the single previous study that evaluated CBR2 expression in breast cancer reported that high CBR2 expression in HER2 positive tumours was associated with poor prognosis [27]. The gene discussed is ERBB2; the disease is neoplasm.